-
1.THIAZOLE INTERMEDIATES USEFUL IN THE PREPARATION OF RAF KINASE INHIBITORS 审中-公开
标题翻译: 噻唑类中间体可用于制备RAF激酶抑制剂公开(公告)号:EP3231798A1
公开(公告)日:2017-10-18
申请号:EP17168722.1
申请日:2008-06-30
发明人: CHEN, Weirong , COSSROW, Jennifer , FRANKLIN, Lioyd , GUAN, Bing , JONES, John, Howard , KUMARAVEL, Gnanasambandam , LANE, Benjamin , LITTKE, Adam , LUGOVSKOY, Alexey , PENG, Hairuo , POWELL, Noel , RAIMUNDO, Brian , TANAKA, Hiroko , VESSELS, Jeffrey , WYNN, Thomas , XIN, Zhili
IPC分类号: C07D401/12 , C07D401/14 , C07D403/12 , C07D413/14 , C07D417/12 , C07D417/14 , C07D471/04 , C07D473/00 , C07D487/04 , A61K31/506 , A61P29/00 , A61P35/00
摘要: The present invention provides compounds useful as inhibitors of Raf protein kinase. The present invention also provides compositions thereof, and methods of treating Raf-mediated diseases.
摘要翻译: 本发明提供可用作Raf蛋白激酶抑制剂的化合物。 本发明还提供了其组合物和治疗Raf介导的疾病的方法。
-
公开(公告)号:EP3231798B1
公开(公告)日:2019-10-09
申请号:EP17168722.1
申请日:2008-06-30
发明人: CHEN, Weirong , COSSROW, Jennifer , FRANKLIN, Lioyd , GUAN, Bing , JONES, John, Howard , KUMARAVEL, Gnanasambandam , LANE, Benjamin , LITTKE, Adam , LUGOVSKOY, Alexey , PENG, Hairuo , POWELL, Noel , RAIMUNDO, Brian , TANAKA, Hiroko , VESSELS, Jeffrey , WYNN, Thomas , XIN, Zhili
IPC分类号: C07D401/12 , C07D401/14 , C07D403/12 , C07D413/14 , C07D417/12 , C07D417/14 , C07D471/04 , C07D473/00 , C07D487/04 , A61K31/506 , A61P29/00 , A61P35/00
-
公开(公告)号:EP2167489A2
公开(公告)日:2010-03-31
申请号:EP08772238.5
申请日:2008-06-30
发明人: CHEN, Weirong , COSSROW, Jennifer , FRANKLIN, Lioyd , GUAN, Bing , JONES, John, Howard , KUMARAVEL, Gnanasambandam , LANE, Benjamin , LITTKE, Adam , LUGOVSKOY, Alexey , PENG, Hairuo , POWELL, Noel , RAIMUNDO, Brian , TANAKA, Hiroko , VESSELS, Jeffrey , WYNN, Thomas , XIN, Zhili
IPC分类号: C07D401/12
CPC分类号: C07D417/14 , A61K31/506 , A61K31/52 , A61K31/5377 , A61K31/675 , A61K45/06 , C07D401/12 , C07D401/14 , C07D403/12 , C07D413/14 , C07D417/12 , C07D471/04 , C07D473/00 , C07D487/04 , C07F9/65583
摘要: The present invention provides compounds useful as inhibitors of Raf protein kinase. The present invention also provides compositions thereof, and methods of treating Raf-mediated diseases.
摘要翻译: 本发明提供可用作Raf蛋白激酶抑制剂的化合物。 本发明还提供了其组合物和治疗Raf介导的疾病的方法。
-
-